← Alle mensen

EK

Ernesto Korbenfeld

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Gevorderd NSCLC: A Gerandomiseerde, Double-Blind, E...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-11

Totale overleving with Amivantamab-Lazertinib in EGFR-Mutated Gevorderd NSCLC.

The New England journal of medicine · 30 oktober 2025

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer:...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 mei 2025

Amivantamab plus lazertinib als eerstelijns bij EGFR-gemuteerd NSCLC: MARIPOSA fase III definitief

The New England journal of medicine · 24 oktober 2024

Subcutaan versus IV amivantamab plus lazertinib bij EGFR-gemuteerd NSCLC: PALOMA-3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2024

Olaparib bij mCRPC met HRR-alteraties: real-world analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 februari 2024

Olaparib-werkzaamheid bij mCRPC met BRCA1, BRCA2 en ATM-mutaties: PROfound subanalyse

Clinical cancer research : an official journal of the American Association for Cancer Research · 4 januari 2023